The impact of the commencement time of hydrogel wound covering/protective material (Episil) for oral mucositis caused by chemotherapy and radiotherapy on cancer patients and cancer treatments. - A prospective observational study
Not Applicable
- Conditions
- Head and neck cancer, Hematological malignancy
- Registration Number
- JPRN-UMIN000041462
- Lead Sponsor
- Iigata University
- Brief Summary
When our results compare with that of historical control, the degree of pain was better than both the expected value and the threshold value of our setting. The incidence of grade 3 oral mucositis was 14%, which was lower than the incidence of chemoradiotherapy and IMRT.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 45
Inclusion Criteria
Not provided
Exclusion Criteria
1)Oral cancer patients. 2)Patients with wounds except for oral mucositis caused by chemotherapy or radiotherapy. 3)Patients with pain management using opioids before the commencement of hydrogel wound covering/protection material application. 4)Patients who are determined to be inappropriateb y the attending physician.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Oral pain
- Secondary Outcome Measures
Name Time Method Oral mucositis Body weight Administration of opioid Blood test results